This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07303/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07303/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07303/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07303/identifier/chemspider/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n5http://linked.opendata.cz/resource/drugbank/drug/DB07303/identifier/pdb/

Statements

Subject Item
n2:DB07303
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n9:DB07303 n11:DB07303
dcterms:title
N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE
adms:identifier
n4:DB07303 n5:9IP n12:9675295 n13:11500493 n14:99443774
n6:IUPAC-Name
n7:271B5E21-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B5E27-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B5E26-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B5E23-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B5E24-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B5E25-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B5E1F-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B5E20-363D-11E5-9242-09173F13E4C5 n7:271B5E1D-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B5E1E-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B5E2D-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B5E2E-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B5E28-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B5E29-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B5E2B-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B5E2A-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B5E2C-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B5E32-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B5E34-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B5E35-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B5E31-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B5E30-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B5E33-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B5E22-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B5E2F-363D-11E5-9242-09173F13E4C5